ClinicalTrials.Veeva

Find clinical trials for Lymphoma in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Salt Lake City, UT, USA:

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1

Acerta Pharma
Acerta Pharma

Salt Lake City, Utah, United States and 31 other locations

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Salt Lake City, Utah, United States and 125 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Salt Lake City, Utah, United States and 215 other locations

Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize t...

Enrolling
Relapsed or Refractory Lymphomas
Advanced Solid Tumor
Drug: LP-284

Phase 1

Lantern Pharma

West Valley City, Utah, United States of America and 1 other location

T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose-escalation (Part A) and...

Active, not recruiting
Agressive Lymphoma
Diffuse-large B-cell Lymphoma (DLBCL)
Biological: CC-97540

Phase 1

Juno Therapeutics

Salt Lake City, Utah, United States and 13 other locations

The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...

Active, not recruiting
Lymphoma,Non-Hodgkin
Drug: Rituximab
Drug: Placebo

Phase 3

Bayer
Bayer

Salt Lake City, Utah, United States and 188 other locations

This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...

Active, not recruiting
Hodgkin Lymphoma
Drug: doxorubicin
Drug: brentuximab vedotin

Phase 2

Seagen
Seagen

Salt Lake City, Utah, United States and 75 other locations

trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two phases. The primary object...

Enrolling
Non Hodgkin Lymphoma
Drug: Rituximab
Drug: Cyclophosphamide

Phase 1, Phase 2

Artiva Biotherapeutics

Salt Lake City, Utah, United States and 20 other locations

of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Drug: Cyclophosphamide
Genetic: CB-010

Phase 1

Caribou Biosciences

Salt Lake City, Utah, United States and 28 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Enrolling
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Salt Lake City, Utah, United States and 226 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems